A detailed history of Vanguard Group Inc transactions in Beyond Air, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,264,514 shares of XAIR stock, worth $531,095. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,264,514
Previous 1,264,514 -0.0%
Holding current value
$531,095
Previous $682,000 27.71%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.54 - $1.67 $72,783 - $225,089
-134,784 Reduced 9.63%
1,264,514 $682,000
Q1 2024

May 10, 2024

BUY
$1.3 - $2.15 $86,091 - $142,381
66,224 Added 4.97%
1,399,298 $2.43 Million
Q4 2023

Feb 14, 2024

BUY
$1.4 - $2.46 $21,389 - $37,583
15,278 Added 1.16%
1,333,074 $2.61 Million
Q3 2023

Nov 14, 2023

BUY
$2.31 - $4.18 $24,756 - $44,797
10,717 Added 0.82%
1,317,796 $3.04 Million
Q2 2023

Aug 14, 2023

BUY
$4.26 - $6.92 $538,540 - $874,812
126,418 Added 10.71%
1,307,079 $5.57 Million
Q1 2023

May 15, 2023

BUY
$5.65 - $7.56 $273,307 - $365,699
48,373 Added 4.27%
1,180,661 $7.97 Million
Q4 2022

Feb 10, 2023

BUY
$5.47 - $7.9 $2,871 - $4,147
525 Added 0.05%
1,132,288 $7.35 Million
Q3 2022

Nov 14, 2022

BUY
$7.42 - $11.39 $71,358 - $109,537
9,617 Added 0.86%
1,131,763 $8.42 Million
Q2 2022

Aug 12, 2022

BUY
$4.96 - $7.83 $987,521 - $1.56 Million
199,097 Added 21.57%
1,122,146 $7.51 Million
Q1 2022

May 13, 2022

BUY
$6.33 - $9.53 $94,563 - $142,368
14,939 Added 1.65%
923,049 $6.17 Million
Q4 2021

Feb 14, 2022

BUY
$8.44 - $15.61 $1.28 Million - $2.36 Million
151,369 Added 20.0%
908,110 $8.57 Million
Q3 2021

Nov 12, 2021

BUY
$5.9 - $12.54 $32,414 - $68,894
5,494 Added 0.73%
756,741 $8.41 Million
Q2 2021

Aug 13, 2021

BUY
$4.72 - $7.15 $3.55 Million - $5.37 Million
751,247 New
751,247 $4.87 Million

Others Institutions Holding XAIR

About Beyond Air, Inc.


  • Ticker XAIR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,888,000
  • Market Cap $12.6M
  • Description
  • Beyond Air, Inc. operates as a commercial medical device and biopharmaceutical company. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment ...
More about XAIR
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.